Group 1 - The stock price of MicroPort Scientific Corporation-B (02252) rose by 7.25%, reaching HKD 28.12, with a trading volume of HKD 310 million [4]. - Nvidia and Eli Lilly announced a joint investment of USD 1 billion to establish an AI drug discovery laboratory, exploring opportunities in clinical development, manufacturing, and commercial operations using AI and robotics [4]. - A report from Zhongyou Securities indicates that the surgical robotics industry may enter a period of commercialization and policy acceleration [4]. Group 2 - As of December 24, MicroPort announced that its cumulative orders for surgical robot products have exceeded 230 units, with over 160 units of laparoscopic surgical robots in global commercial orders [4]. - The company's self-developed bronchoscopic surgical robot "Dudao" has received approval from the NMPA [4]. - Zhongyou Securities believes that the company's globalization strategy is rapidly being validated in the market, with increasing competitiveness overseas [4]. - In the domestic market, the relaxation of policies regarding laparoscopic robot configurations may allow the company to maintain its advantages, and the optimization of charging policies is expected to enhance industry penetration [4].